To further explore the potential clinical value of high CCAT2 expression, the prognostic power of the lncRNA CCAT2 was determined for OS and DFS in 109 ovarian cancer patients, using the Kaplan-Meier method and log-rank test. This evidence concerns the gene CCAT2 and ovarian cancer.